SCHEMBL516592

SCHEMBL516592

C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)C(O)(O)O

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 8/20 0.78
CYP3A4 P08684 7/20 0.78
ALDH1A1 P00352 6/20 0.78
SMN1; SMN2 Q16637 5/20 0.78
MAPT P10636 5/20 0.78
MAPK1 P28482 4/20 0.78
TSHR P16473 4/20 0.78
SHBG P04278 4/20 0.78
SERPINA6 P08185 4/20 0.78
NR3C1 P04150 4/20 0.78
PGR P06401 4/20 0.78
AR P10275 3/20 0.78
GPBAR1 Q8TDU6 3/20 0.78
SIGMAR1 Q99720 3/20 0.78
CYP2C9 P11712 2/20 0.78
HIF1A Q16665 2/20 0.78
ABCB11 O95342 2/20 0.78
NR3C2 P08235 2/20 0.78
MEN1 O00255 2/20 0.78
KMT2A Q03164 2/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11702780 0.88 LMNA (0.69) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
Progesterone SCHEMBL3932110 0.87 CYP3A4 (1.00) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
Progesterone SCHEMBL13259536 0.87 CYP3A4 (1.00) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
Progesterone SCHEMBL20409003 0.87 CYP3A4 (1.00) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL23784699 0.87 LMNA (0.83) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL23784747 0.87 LMNA (0.83) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL23784700 0.87 LMNA (0.83) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
Progesterone SCHEMBL23568915 0.87 CYP3A4 (1.00) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
Progesterone SCHEMBL7671 0.87 CYP3A4 (1.00) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL12424000 0.87 LMNA (0.83) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113528474-B 3-sterone-delta1Dehydrogenase and coding gene and application thereof 中国科学院天津工业生物技术研究所 2021-12-10 CN claimed
CN-111349677-B Biocatalysis preparation method of steroid C1, 2-position dehydrogenation drug intermediate 中国科学院天津工业生物技术研究所 2021-11-12 CN claimed
CN-113528474-A 3-sterone-delta1Dehydrogenase and coding gene and application thereof 中国科学院天津工业生物技术研究所 2021-10-22 CN claimed
CN-111349677-A Biocatalysis preparation method of steroid C1, 2-position dehydrogenation drug intermediate 中国科学院天津工业生物技术研究所 2020-06-30 CN claimed
US-20120028910-A1 STORAGE-STABLE AQUEOUS OPHTHALMIC FORMULATIONS FOVEA PHARMACEUTICALS (FR) 2012-02-02 US claimed
US-5001116-A Inhibition of angiogenesis THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 1991-03-19 US claimed
EP-0350488-A1 1,2-DEHYDROGENATION OF STEROIDAL 21-ESTERS WITH A. SIMPLEX. UPJOHN CO (US) 1990-01-17 EP claimed
WO-1988007092-A1 1,2-DEHYDROGENATION OF STEROIDAL 21-ESTERS WITH A. SIMPLEX THE UPJOHN COMPANY (US) 1988-09-22 WO claimed
US-4296233-A Conjugate of amino sugar-steroid hormone KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1981-10-20 US claimed
JP-11228420-A None JP disclosed
CN-118079817-A Hydrocortisone preparation method and hydrocortisone preparation device 西安国康瑞金制药有限公司 2024-05-28 CN disclosed
EP-4291571-A2 ACTIVITY-INDUCIBLE FUSION PROTEINS HAVING A HEAT SHOCK PROTEIN 90 BINDING DOMAIN Seattle Children's Hospital d/b/a Seattle Children's Research Institute (US) 2023-12-20 EP disclosed
WO-2023230175-A1 COMPOSITIONS FOR TREATMENT OF ANAL GLAND DISEASE VETNIQUE LABS, LLC (US) 2023-11-30 WO disclosed
CN-116615210-A Novel anuclear cells as a source for the treatment of platelet-rich plasma-dependent disorders 血小板生源说股份有限公司 2023-08-18 CN disclosed
US-4588683-A Method of preparing 11β, 17α, 20, 21-tetrahydroxy steroids and corresponding 11β, 17α, 21-trihydroxy-20-oxo steroids EASTMAN KODAK COMPANY (US) 1986-05-13 US disclosed
EP-0154407-A2 Methods of preparing 11 beta, 17 alpha, 20, 21-tetra-hydroxy steroids and corresponding 11 beta, 17 alpha, 21-trihydroxy-20-oxo steroids EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1985-09-11 EP disclosed
EP-0014991-A1 Microbiological method for the preparation of 7-alpha-hydroxylated steroids F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1980-09-03 EP disclosed
US-4001219-A STEROIDAL DERIVATIVES OF BENDAZOLIC ACID AND PROCESS FOR THE PREPARATION OF THE SAME BAIOCCHI LEANDRO 1977-01-04 US disclosed
US-3978203-A SUSTAINED RELEASE OF PHARMACEUTICALS FROM POLYESTER MATRICES DYNATECH CORPORATION (US) 1976-08-31 US disclosed
US-3956349-A TRIETHYL ORTHOACETATE, ACID CATALYST SYNTEX (U.S.A.) INC. (US) 1976-05-11 US disclosed